Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Harnessing Biologic Development Experience in Support of CDMO Clients | Contract Pharma

What are you searching for?

Sign in
Sponsored Content

Harnessing Biologic Development Experience in Support of CDMO Clients

Rapid, Effective and Tailored Analytical Method Development

Released By Bora Biologics

Successfully advancing biopharmaceutical drug candidates from early development to clinical trials, and eventually to commercialization, requires a systematic approach and in-depth consideration of analytical method development and validation needs. With development timelines continuing to shrink and impacting priorities, there is a growing risk that drug developers may give insufficient emphasis and attention to these analytical functions that are crucial to the life cycle of a biopharmaceutical product. Working with a contract development and manufacturing organization (CDMO) that has a legacy of experience developing biosimilars on the path to commercialization can ensure comprehensive product and process analysis using robust, fit-for-purpose methods in a compliant manner, all while supporting shortened timelines.

Click here to read the full article >>

Request more information from Bora Biologics

Request more information from Bora Biologics

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters